1887
Research Open Access
Like 0

Abstract

Background

Zoonotic influenza, including infections with avian and swine influenza A viruses (swIAV), is a notifiable disease in the Netherlands. Human cases infected with swIAV have previously been rarely detected in the Netherlands.

Aim

We aimed to describe detection and characterisation of Eurasian avian-like swIAV infections in humans in the Netherlands 2020–2023.

Methods

The Dutch National Influenza Center coordinates different activities to monitor respiratory infections and circulating human influenza viruses. This monitoring includes sentinel surveillance in general practitioner practices, community participatory surveillance and characterisation of influenza viruses received from diagnostic laboratories. A subset of the specimens positive for influenza A virus from the monitoring activities are sent for further characterisation. We characterised swIAV from human patients using whole genome sequencing, tested the viruses for antiviral susceptibility and in haemagglutination inhibition assays for antigenic characterisation and compared them with previous detections from humans and pigs.

Results

Avian-like swine influenza virus was detected in three persons presenting with mild respiratory symptoms, and all recovered fully. Only one patient had close contact with pigs shortly before the start of symptoms. Sequence analyses of the viruses showed clustering with swAIV from pigs in a recently initiated surveillance system on pig farms.

Conclusions

These human cases show that swIAV viruses with zoonotic potential are enzootic in the Netherlands. Finding them by coincidence suggests human infections might occur more frequently than noticed.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2025.30.19.2400662
2025-05-15
2025-05-17
/content/10.2807/1560-7917.ES.2025.30.19.2400662
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/30/19/eurosurv-30-19-2.html?itemId=/content/10.2807/1560-7917.ES.2025.30.19.2400662&mimeType=html&fmt=ahah

References

  1. Chepkwony S, Parys A, Vandoorn E, Stadejek W, Xie J, King J, et al. Genetic and antigenic evolution of H1 swine influenza A viruses isolated in Belgium and the Netherlands from 2014 through 2019. Sci Rep. 2021;11(1):11276.  https://doi.org/10.1038/s41598-021-90512-z  PMID: 34050216 
  2. Lewis NS, Russell CA, Langat P, Anderson TK, Berger K, Bielejec F, et al. The global antigenic diversity of swine influenza A viruses. eLife. 2016;5:e12217.  https://doi.org/10.7554/eLife.12217  PMID: 27113719 
  3. Watson SJ, Langat P, Reid SM, Lam TT, Cotten M, Kelly M, et al. Molecular epidemiology and evolution of influenza viruses circulating within European swine between 2009 and 2013. J Virol. 2015;89(19):9920-31.  https://doi.org/10.1128/JVI.00840-15  PMID: 26202246 
  4. Freidl GS, Meijer A, de Bruin E, de Nardi M, Munoz O, Capua I, et al. Influenza at the animal-human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1). Euro Surveill. 2014;19(18):20793.  https://doi.org/10.2807/1560-7917.ES2014.19.18.20793  PMID: 24832117 
  5. McBride DS, Perofsky AC, Nolting JM, Nelson MI, Bowman AS. Tracing the source of influenza A virus zoonoses in interconnected circuits of swine exhibitions. J Infect Dis. 2021;224(3):458-68.  https://doi.org/10.1093/infdis/jiab122  PMID: 33686399 
  6. Bowman AS, Walia RR, Nolting JM, Vincent AL, Killian ML, Zentkovich MM, et al. Influenza A(H3N2) virus in swine at agricultural fairs and transmission to humans, Michigan and Ohio, USA, 2016. Emerg Infect Dis. 2017;23(9):1551-5.  https://doi.org/10.3201/eid2309.170847  PMID: 28820376 
  7. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009;325(5937):197-201.  https://doi.org/10.1126/science.1176225  PMID: 19465683 
  8. de Jong JC, de Ronde-Verloop JM, Bangma PJ, van Kregten E, Kerckhaert J, Paccaud MF, et al. Isolation of swine-influenza-like A(H1N1) viruses from man in Europe, 1986. Lancet. 1986;2(8519):1329-30.  https://doi.org/10.1016/S0140-6736(86)91450-9  PMID: 2878189 
  9. de Jong JC, Paccaud MF, de Ronde-Verloop FM, Huffels NH, Verwei C, Weijers TF, et al. Isolation of swine-like influenza A(H1N1) viruses from man in Switzerland and The Netherlands. Ann Inst Pasteur Virol. 1988;139(4):429-37.  https://doi.org/10.1016/S0769-2617(88)80078-9  PMID: 3214596 
  10. Fraaij PL, Wildschut ED, Houmes RJ, Swaan CM, Hoebe CJ, de Jonge HC, et al. Severe acute respiratory infection caused by swine influenza virus in a child necessitating extracorporeal membrane oxygenation (ECMO), the Netherlands, October 2016. Euro Surveill. 2016;21(48):30416.  https://doi.org/10.2807/1560-7917.ES.2016.21.48.30416  PMID: 27934581 
  11. Meijer A, Swaan CM, Voerknecht M, Jusic E, van den Brink S, Wijsman LA, et al. Case of seasonal reassortant A(H1N2) influenza virus infection, the Netherlands, March 2018. Euro Surveill. 2018;23(15):18-00160.  https://doi.org/10.2807/1560-7917.ES.2018.23.15.18-00160  PMID: 29667576 
  12. Parys A, Vandoorn E, King J, Graaf A, Pohlmann A, Beer M, et al. Human Infection with Eurasian avian-like swine influenza A(H1N1) virus, the Netherlands, September 2019. Emerg Infect Dis. 2021;27(3):939-43.  https://doi.org/10.3201/eid2703.201863  PMID: 33622472 
  13. Rimmelzwaan GF, de Jong JC, Bestebroer TM, van Loon AM, Claas EC, Fouchier RA, et al. Antigenic and genetic characterization of swine influenza A (H1N1) viruses isolated from pneumonia patients in The Netherlands. Virology. 2001;282(2):301-6.  https://doi.org/10.1006/viro.2000.0810  PMID: 11289812 
  14. Donker GA. NIVEL Primary Care Database - Sentinel Practices 2015. NIVEL: Utrecht; 2016. Available from: https://www.nivel.nl/nl/publicatie/nivel-primary-care-database-sentinel-practices-2015
  15. Smit T, Carstens G, Han W, Bulsink K, de Bakker J, Elahi M, et al. Flexible and scalable participatory syndromic and virological surveillance for respiratory infections: our experiences in The Netherlands. medRxiv. 2024:2024.04.24.24306278 . https://doi.org/10.1101/2024.04.24.24306278 
  16. Meijer A, Beerens A, Claas E, Hermans M, de Jong A, Molenkamp R, et al. Preparing the outbreak assistance laboratory network in the Netherlands for the detection of the influenza virus A(H1N1) variant. J Clin Virol. 2009;45(3):179-84.  https://doi.org/10.1016/j.jcv.2009.06.003  PMID: 19540155 
  17. Mackenzie GA, Vilane A, Salaudeen R, Hogerwerf L, van den Brink S, Wijsman LA, et al. Respiratory syncytial, parainfluenza and influenza virus infection in young children with acute lower respiratory infection in rural Gambia. Sci Rep. 2019;9(1):17965.  https://doi.org/10.1038/s41598-019-54059-4  PMID: 31784567 
  18. van der Vries E, Germeraad EA, Kroneman A, Dieste Pérez L, Eggink D, Willems E, et al. Swine influenza virus surveillance program to assess the risk for animal and public health in the Netherlands, 2022-2023. Euro Surveill. 2025; (Forthcoming).
  19. Zhou B, Donnelly ME, Scholes DT, St George K, Hatta M, Kawaoka Y, et al. Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol. 2009;83(19):10309-13.  https://doi.org/10.1128/JVI.01109-09  PMID: 19605485 
  20. Jonges M, van der Lubben IM, Dijkstra F, Verhoef L, Koopmans M, Meijer A. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008. Antiviral Res. 2009;83(3):290-7.  https://doi.org/10.1016/j.antiviral.2009.07.003  PMID: 19591877 
  21. de Jong JC, Smith DJ, Lapedes AS, Donatelli I, Campitelli L, Barigazzi G, et al. Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe. J Virol. 2007;81(8):4315-22.  https://doi.org/10.1128/JVI.02458-06  PMID: 17287258 
  22. Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: a review of the literature. Clin Infect Dis. 2007;44(8):1084-8.  https://doi.org/10.1086/512813  PMID: 17366454 
  23. Olsen CW, Brammer L, Easterday BC, Arden N, Belay E, Baker I, et al. Serologic evidence of H1 swine Influenza virus infection in swine farm residents and employees. Emerg Infect Dis. 2002;8(8):814-9.  https://doi.org/10.3201/eid0808.010474  PMID: 12141967 
  24. European Centre for Disease Prevention and Control (ECDC). Zoonotic influenza - Annual Epidemiological Report for 2022. Stockholm: ECDC; 23 May 2023. Available from: https://www.ecdc.europa.eu/en/swine-influenza/surveillance-and-disease-data
  25. Centers for Disease Control and Prevention (CDC). Confirmed Novel Influenza A Virus Infections. Atlanta: CDC. [Accessed: 14 May 2025]. Available from: https://gis.cdc.gov/grasp/fluview/Novel_Influenza.html
  26. World Health Organization (WHO). 2023: outbreaks of swine influenza. Geneva: WHO; 30 Mar 2024. Available from: https://www.who.int/news/item/30-03-2024-2023--outbreaks-of-swine-influenza
  27. Meng F, Chen Y, Song Z, Zhong Q, Zhang Y, Qiao C, et al. Continued evolution of the Eurasian avian-like H1N1 swine influenza viruses in China. Sci China Life Sci. 2023;66(2):269-82.  https://doi.org/10.1007/s11427-022-2208-0  PMID: 36219302 
  28. Teirlinck AC, de Gier B, Meijer A, Donker G, de Lange M, Koppeschaar C, et al. The incidence of symptomatic infection with influenza virus in the Netherlands 2011/2012 through 2016/2017, estimated using Bayesian evidence synthesis. Epidemiol Infect. 2018;147:e30.  https://doi.org/10.1017/S095026881800273X  PMID: 30348244 
  29. World Health Organization (WHO). Laboratory methodologies for testing the antiviral susceptibility of influenza viruses: Neuraminidase inhibitor (NAI). Geneva: WHO. [Accessed: 14 May 2025]. Available from: https://www.who.int/teams/global-influenza-programme/laboratory-network/quality-assurance/antiviral-susceptibility-influenza/neuraminidase-inhibitor
/content/10.2807/1560-7917.ES.2025.30.19.2400662
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error